COVID-19 äžã®è·å Žåéã§èæ ®ããã¹ãè·å ŽããŒã¿æŠç¥ã® 4 ã€ã®åŽé¢
COVID-19 ã«ãããçµç¹ã¯ç©ççãªè·å Žã®ä»åŸãåèããããåŸãªããªããŸããããã¹ã¯ã®é 眮ãäŒè°å®€ãå ±çšã¹ããŒã¹ãªã©ãããããã®ã«ãåŸæ¥å¡ã®å¥åº·ãšå®å šãšããæ°ããèŠç¹ããåãçµãå¿ èŠããããŸãããªãŒããŒãåéã®èšç»çå®ãåéã®ããã®ææšã®ææ¡ãå¹æã®è©äŸ¡ãè¡ãäžã§ãéèŠãªåœ¹å²ãæããã®ãããŒã¿ã§ãã
äžçãæšç§»ãèŠå®ãåŠãã§ãããªãã§ãäžéšã®åœã§ã¯ãã§ã«ãªãã£ã¹ã®åéãå§ãŸã£ãŠããŸããã¬ãŒãããŒç€Ÿ (è±èª) ã«ãããšãã¢ãžã¢å€ªå¹³æŽå°åã§ãããŸã§åŸãããæãéèŠãªç¥èãšããŠããéææ§ããšãå埩ãã®å€§åãã 1 ã€æããããŸããSalesforce 瀟æé«ããŒã¿è²¬ä»»è ã® Hernan Asorey ã¯ã次ã®ããã«èª¬æããŠããŸããã人ã¯ãææ決å®ã§å©çšã§ããããŒã¿ãåžžã«è©äŸ¡ããŠããŸããå€åããããããããŒãºã«å¯ŸããŠãä¿¡çšã§ããæ å ±æºããäœãåŸãããããå®å©çã«èª¿ã¹ããã®åéã®å°é家ãšãšãã«åå³ããåŸãè©äŸ¡ãæ¡åŒµãåŠç¿ãé å¿ããŸãã
çµç¹ã¯ããªãã£ã¹ã®å Žæãè·å Žã®ã¿ã€ããåŸæ¥å¡èŠæš¡ãªã©å€æ§ãªèŠçŽ ã«å·Šå³ãããããŸã£ããæ°ããçš®ã ã®èª²é¡ã«çŽé¢ããŠããããããªãŒããŒã¯èšç»çå®ãžã®æè»ãªã¢ãããŒãã«æŽ»çšã§ããããŒã¿ãå¿ èŠãšããŠããŸãã
ãã®ããã°ã§ã¯ãåéã®æŠç¥ã§ããŒã¿ã圹ç«ã€æ¬¡ã® 4 ã€ã®åŽé¢ãåãäžããŸãã
- COVID-19 ã¿ã¹ã¯ãã©ãŒã¹ã®æ§ç¯
- å°åã®æ¿çã®è¿œè·¡
- ããŒã¿ãå©çšãããªãã£ã¹èšç»
- åŸæ¥å¡èª¿æ»ããŒã¿ã®åæ
ããã«æããã®ã¯ä»£è¡šçãªãã®ã§ããããã¹ãŠãç¶²çŸ ãããŠããã§ã¯ãããŸãããçµç¹ã«ãã£ãŠçŽ°ããç¹ã¯ç°ãªãããããã®ããã°ã¯æ å ±æäŸã®ã¿ãç®çãšããŠããŸããè·å Žãå®å šãã€å¹ççã«åéããããã®è©³ããæ¹æ³ã«ã€ããŠã¯ãSalesforce 瀟㮠Work.com ãã芧ãã ããã
1.ããŒã¿ã«æ¯ãããã COVID-19 ã¿ã¹ã¯ãã©ãŒã¹ã®æ§ç¯
åéã«ã¯ãéšéã®æ ãè¶ ããåãçµã¿ãå¿ èŠã§ããå€ãã®çµç¹ããå€æ§ãªã¹ãã«ã»ãããèŠç¹ãæã£ãããŸããŸãªäººã ãåå ãããäžå åããã COVID-19 æ åœã¿ã¹ã¯ãã©ãŒã¹ãèšããŠãè·å Žã®èšåãåŸæ¥å¡ãžã®åšç¥ãªã©ã®çŽ°ããéšåã管çããŠããŸããSalesforce 瀟ã®ã¬ã€ããããžãã¹ãåéããã«ã¯ã (è±èª) ã§ãå瀟ã®ã°ããŒãã«äžåç£éšéãšã°ãŒã¯ãã£ããã€ã¹ãã¬ãžãã³ãã® Elizabeth Pinkham ã¯ãã¿ã¹ã¯ãã©ãŒã¹ãå šåŸæ¥å¡ã代衚ããããã«ãªã£ãŠããããšãéèŠã ãšè¿°ã¹ãŠããŸãã
ãTableau ã§ã¯ãè·å Žã«é¢ãããã£ã¹ã«ãã·ã§ã³ã«å¹ åºãé¢ä¿è ãåå ãããŠããŸãããšãTableau ã¯ãŒã¯ãã¬ãŒã¹æ åœã·ãã¢ãããŒãžã£ãŒã® Debbie Smith ã¯èªããŸããããTableau ã¯ãèŠåã人äºãäžåç£ãããŒã±ãã£ã³ã°ã賌買ãªã©ãäŒç€Ÿã®ãããšããããé¢ããã®èŠç¹ãšããŒã¿ãå©çšããŠããŸãããŸãã瀟å€ã®å°é家ãæããŠãèœåèšç»ã空æ°ãéãªã©ã®è©³çŽ°ãªæ å ±ãåãå ¥ããŠããŸãã
é¢ä¿è ã¯å šå¡ãç°ãªãããŒã¿ãã€ã³ããèªèº«ã®èŠç¹ã®æ å ±æºã«ããŸããããšãã°ãå®å šè¡çããŒã ã¯å°åã®æ¿çããŒã¿ãã¢ãã¿ãªã³ã°ãã賌買ããŒã ã¯ãã¹ã¯éã®ããã«ãªã©ã®æ°ããååã®è³Œå ¥ã«ããŒã¿ã圹ç«ãŠãããšãããã§ãããããŸããIT ããŒã ã¯è·å ŽããŒã ãšååããŠãé»è©±ããããã»ãããªã©ã®æ¢åååã®å ¥ãæ¿ãæ¹æ³ã決ããããšã«ãªããããããŸããã
ããŒã¿ã¯ã䜿ã人ãç¶æ³ãšé¢é£ä»ããŠè¡åã«ç§»ããå Žåã«åããŠåœ¹ã«ç«ã€ãããåéã®æŠç¥ã§ã¯å°ä»»ããŒã ã®èšçœ®ã第äžæ©ã«ãªããŸãã
2.åéã«åããæ å ±æºãšããŠå©çšããå°åæ¿çããŒã¿ã®è¿œè·¡
åéã®æŠç¥ã¯ãå°åã®æ¿çã«ãã£ãŠå€§ããå·Šå³ãããŸããæ¿ç以å€ã«ããç±³åœã®çµç¹ã¯åŽåå®å šè¡çå± (OSHA)ãçŸç äºé²ç®¡çã»ã³ã¿ãŒ (CDC)ãç°å¢ä¿è·åº (EPA) ãªã©ã«ããæ°å€ãã®æéã«åŸãå¿ èŠããããŸãã
å€ãã®çµç¹ã¯ãå€ããããæ¿çã远跡ããå®å šã«ãªãã£ã¹ãåéã§ããææãèŠæ¥µããããã®éèŠãªææšã圹ç«ãŠãããšãäžå çãªããã·ã¥ããŒãã§èª¿ã¹ãŠããŸããããšãã° SC&H Group 瀟ã®ããŒã¿åæããŒã ã¯ãç±³åœã®äŒæ¥ã«ãšã£ãŠåèã«ãªããµã³ãã«ããã·ã¥ããŒããäœæããŸããããã®ããã·ã¥ããŒãã§ã¯å·å¥ã®æ³åŸãšãšãã«ãææè æ°ã瀺ããããã衚瀺ãããŠããŸãã
ã¯ã·ã³ãã³å€§åŠã§æ¿æ²»åŠåææãšçµ±èšåŠéåžžå€åææãåãã Christopher Adolph æ°ã¯ããªãŒãã³ãœãŒã¹ã®ããŒã¿ã䜿ã£ãŠãCOVID-19 é¢é£ã®å·æ¿çã«é¢ããããŒã¿ã»ãããæŽåãä¿å®ããŠããŸããAdolph æ°ã¯ããŒã¿ãåæã®ãªãŒããŒã«å¯ŸããŠãå°åã®æ¿çããŒã¿ã®ããžã¥ã¢ã«åã§ã¯çŠç¹ãçµã£ãã¢ãããŒããåãããšãå§ããŠããŸããããã¯ã€ãŸããCOVID-19 ã®åœ±é¿ã瀺ãå°åçãªç¹å®ã®ææšã«çŠç¹ãçµãããã«ãããã以å€ã®ããžã¥ã¢ã©ã€ãŒãŒã·ã§ã³ã¿ã€ããæ€èšããããšã ãšèšã£ãŠãããã§ãããã
Adolph æ°ã¯æ¬¡ã®ããã«è¿°ã¹ãŠããŸãããç§ãçµç¹ã ã£ãããäœæããããžã¥ã¢ã©ã€ãŒãŒã·ã§ã³ã§ãäºæ¥ã«é¢ä¿ãããããããã®å Žæã§èµ·ãã£ãŠããããšã瀺ãã€ã€ããŠãŒã¶ãŒãæ¿çã®å³æ Œãã移åã®ãã¬ã³ããææè æ°ã®ãã¬ã³ãã§äžŠã¹æ¿ããããããã«ãããã£ã«ã¿ãŒãèšããã§ãããããããŠãå°åã§ææè æ°ãå¢å ãŸãã¯æžå°ããã®ã«äŒŽã£ãŠãæ¿çãã©ã®ããã«å€åããŠããããæç³»åã§èŠãããšæãã§ãããã
Tableau ããŒãããŒã® Lovelytics 瀟ããTableau COVID-19 ããŒã¿ããã®ããŒã¿ããµã³ãã«ã®äººäºããŒã¿ãšçµã¿åãããŠã建ç©ã幎霢局ãå Žæããšã§ãªã¹ã¯ã«ãããããŠããåŸæ¥å¡ã®å èš³ã瀺ãããã·ã¥ããŒãã®ãã³ãã¬ãŒããäœæããŸããããã®äŸã¯å ã ãå±æ©äžã§å®å®ãç®æãäŒæ¥ã®ããã«äœæããããã®ã§ããããã®çš®ã®ããã·ã¥ããŒãã¯ãåéåŸã«æ°åã³ãããŠã€ã«ã¹ã®æ°ããªæ³¢ãçºçããå Žåãäžå åãããä¿¡é Œã§ããæ å ±æºã«ãªãå¯èœæ§ããããŸãã
3.ããŒã¿ãå©çšãããªãã£ã¹èšç» (ãã¹ã¯ã®é 眮ãå¯é床ãªã©)
COVID-19 åŸã«çµç¹ãçŽé¢ããæãè€éãªèª²é¡ã®ãã¡ãããã€ãã¯è·å Žã®ã¬ã€ã¢ãŠãã«é¢é£ããŠããŸããå€ãã®çµç¹ã§ã¯ãªãŒãã³ãªãã£ã¹ã®ã³ã³ã»ãããåãå ¥ããããŠãããããåŸæ¥å¡ã®ééã 6 ãã£ãŒã (çŽ 2 m) 以äžç©ºãããšããæ瀺ãå®ãããšãé£ãããªããŸãããŸãããããã³ããã€ã¬ããšã¬ããŒã¿ãŒãªã©ã®å ±çšã¹ããŒã¹ã®å©çšããããŠæææ§é£æ²«ã®æ¡æ£ãæããé«æ§èœç©ºæ°ãéã·ã¹ãã ãè©äŸ¡ããŠããçµç¹ã¯å°ãªããããŸãããçµç¹ãããããèšåäžã®ãã¹ãŠã®æ±ºå®ãè«ççã«è¡ãããã®æ段ãšããŠã1 ã€æããããã®ãããŒã¿ã®å©çšã§ãã
ã¹ããŒã¹ã®äœ¿ãæ¹ã«é¢ããŠçµç¹ãåéããŠãã (ãããã¯åéãæ€èšããŠãã)ãäž»ãªããŒã¿ãã€ã³ãã®äŸãšããŠã¯æ¬¡ã®ãã®ãæããããŸãã
- ç©ççãªè·é¢ (ãã¹ã¯éãå ±çšã¹ããŒã¹å )
- ã¹ããŒã¹ã®æŽç (ãããã³ãäŒè°å®€ãªã©ã®å ±çšã¹ããŒã¹ã§å®¶å ·ãæžãã)
- 空æ°ã®åããšææ°
- ãšã¬ããŒã¿ãŒããã€ã¬ãªã©ã®æ»çå Žæ
ããããæ°ããªèª²é¡ã«ãããçµç¹ã¯è·å Žã®æ°å€çãªåºæºã«å¯ŸããŠæ°ããã¢ãããŒããåãã€ã€ãããŸããããšãã° Salesforce 瀟ã¯ãããŒã¿ãåæããŠæå·®åºå€ãã¢ããªã³ã°ãããšã¬ããŒã¿ãŒã®å©çšäººæ°ãããŸã管çã§ããããã«ããŠããŸããããšã¬ããŒã¿ãŒåŸ ã¡ãé·ãããã§ãåŸæ¥å¡ããããŒãå€ã®æ©éã«ãŸã§ããµããç¶æ³ã¯çµ¶å¯Ÿã«é¿ããªããã°ãªããŸããããšãElizabeth Pinkham ã¯è¿°ã¹ãŸãããSalesforce 瀟ã¯ãŸããçµç¹ã人æ°ãšå Žæã®ããŒã¿ã管çããŠæ¥è§Šè 远跡ããã»ã¹ãè£åŒ·ã§ããããã«ãã (èŠãªããã€ã³)ããã¿ããã¬ã¹ãªãã£ã¹ã (è±èª) ã®äž»ãªãœãªã¥ãŒã·ã§ã³ã§ãSiemens 瀟ãšããŒãããŒã·ãããçµãã§ããŸãã
ã°ããŒãã«åæ¥äžåç£ãµãŒãã¹äŒç€Ÿã® Cushman & Wakefield 瀟 (è±èª) ã¯ã埩垰ãžã®æºåãã¬ã€ãã§ãçµç¹ã¯ããã«ã·ã¹ãã ãšã¯ãŒã¯ãã¬ãŒã¹ã·ã¹ãã ã®çµ±åãå¯èŠæ§ã管çã匷åããã(人æã»ã³ãµãŒã空æ°è³ªç£èŠæ©èœãªã©ã®) éçšå¯èœãªãã«ãã¯ãããžãŒã«æè³ããããšããã§ããããšè¿°ã¹ãŠããŸããå瀟ã¯ããã«ãã6 ãã£ãŒããªãã£ã¹ã (è±èª) ãšèŠãªãããæ°ãããªãã£ã¹ã¬ã€ã¢ãŠããã¢ã ã¹ãã«ãã ã§å è¡å°å ¥ãã倧ããªåãšèŠèŠãã¥ãŒãçšããŠåŸæ¥å¡ã®ééã 6 ãã£ãŒã空ããããŠããŸãã
å ãã Tableau Zen Master ã® Ken Flerlage æ°ã¯ãåãã¹ã¯ã®åšãã« 6 ãã£ãŒãã®åãæããŠããªãã£ã¹ç©ºéã®ããžã¥ã¢ã©ã€ãŒãŒã·ã§ã³äŸãè©ŠäœããŸããããã¹ã¯ãšãªã¢ã 6 ãã£ãŒãééã«åŸã£ãŠããªãå Žåãåã¯èµ€ããªã£ãŠããªãã£ã¹ç©ºéã®ã¬ã€ã¢ãŠããåèããå¿ èŠãããããšãç¥ãããŸããããžã¥ã¢ã©ã€ãŒãŒã·ã§ã³ã«é¢ãã Flerlage æ°ã®ããã° (è±èª) ã§ãExcella 瀟ã®ããŒã¿ããžã¥ã¢ã©ã€ãŒãŒã·ã§ã³ãªãŒããåãã Amanda Makulec æ°ãšãTeknion 瀟ã®ã·ãã¢ã³ã³ãµã«ã¿ã³ããåãã Bridget Cogley æ°ã¯ããã®ãµã³ãã«ã¯ãªãã£ã¹ã®åº§åžé 眮ãèŠçŽãããã§è¯ãåºçºç¹ã«ãªããšèªã£ãŠããŸãããããããªãã£ã¹ç°å¢ã®è€éãªåç·ã«ã€ããŠãæ€èšãéããå¿ èŠããããšãä»ãå ããŸããã
äŒæ¥ã®äžã«ã¯ããã®è€éããèæ ®ã«å ¥ããããã«ã瀟å€ã®å°é家ã«ãã©ã¡ãŒã¿ãŒã®èšå®ãäŸé Œããèšåèšç»ã«åœ¹ç«ãŠãŠãããšããããããŸããããããæ§æ³ã¯åžžã«ãçµç¹ãå®è¡ã«ç§»ãéçšã§ããã«ç·ŽãçŽããæè»ã«å¯Ÿå¿ããŠããå¿ èŠããããŸãã
4.åŸæ¥å¡ã®ã¡ã³ã¿ã«ãã«ã¹ãšå¥åº·ã«é¢ãã調æ»ããŒã¿ã®åæ
åŸæ¥å¡ããªãã£ã¹ã«æ»ãããã©ããã«ããããããçµç¹ã¯åŸæ¥å¡ã®ããŒãºãèæ ®ããå¿ èŠããããŸããåŸæ¥å¡ã¯ãªãã£ã¹ã«æ»ãããšã«æµæãæããŠããªãã§ãããããæããŠããªãå Žåãããã¯ã©ãã ãå¯èœãªã®ã§ãããããåŸæ¥å¡ã®äžã«ã¯ãäŒæ ¡ãç¶ããŠããããã«åã©ããšå®¶ã«ããå¿ èŠããã人ãå ç«äžå šãæ£ã£ãŠãã人ãã¯ã¯ãã³ãäžè¬ã«è¡ãæž¡ããŸã§ãã¬ã¯ãŒã¯ãæã人ããããããããŸããã
Tableau ãªã©ã®äžéšã®äŒæ¥ã¯ãå®æçãªèª¿æ»ãéããŠåŸæ¥å¡ã®æžå¿µãè©äŸ¡ããŠããŸããããšãã°ããã¬ã¯ãŒã¯ã«ã©ã®ãããé©å¿ããŠããããäŒç€Ÿã¯åŸæ¥å¡ãã©ã®ããã«æ¯æŽã§ããããªã©ãå šè¬çãªçŠå©ã«é¢ãã質åãè¡ãããŸãããŸãèšåèšç»ã®æ®µéã«ããäŒæ¥ã¯ãåéã®ã¹ã±ãžã¥ãŒã«ã決ããããã«ãåŸæ¥å¡ããªãã£ã¹ã«æ»ãããšã«æµæãæããŠãããã©ããã«ã€ããŠè³ªåããå Žåãããã§ãããã
ãã®ããŒã¿ãå©çšã§ããããã«ãªã£ãŠãããšãçµç¹ã¯ä»¥äžã®ãã®ãåæã§ããŸãã
- ã¡ã³ã¿ã«ãã«ã¹ã®ãã³ãããŒã¯
- åéã¹ã±ãžã¥ãŒã«ã®æ±ºå®ã«åœ¹ç«ãŠããåŸæ¥å¡ããã®ãã£ãŒãããã¯
- ãªãã£ã¹ååãä¿è²æ¯æŽãµãŒãã¹ãªã©ã®åŸæ¥å¡ã®ããŒãº
ãªãã£ã¹ã®åéåŸãäŒæ¥ã¯ãã®èª¿æ»ããŒã¿ãšå©çšç¶æ³ããŒã¿ãçµåããŠãå®éã«æ¥åžžçã«éå€ããŠããåŸæ¥å¡æ°ã調ã¹ãŠãããã§ããããåŸæ¥å¡ãæ°ããåŽåç°å¢ã«æµæãæããŠããªããã©ãããç¥ãã®ã«åœ¹ç«ã¡ãŸãããŸãçµç¹ã¯ãã·ãããå§æ¥æéãäŒæ©æéããããå¿ èŠãããããããã®ããŒã¿ãåºæºã«ããŠã·ããèšç»ãç«ãŠãããšãã§ããŸãã
çµç¹ã¯èª¿æ»çµæã®åæã«ããããã³ãããã¯ãåŸæ¥å¡ã«åãŒããŠãã圱é¿ã瀺ãéèŠãªææšãäœæããè¡åãåãæ¹æ³ã決ããããšãã§ããããã«ãªããŸãã
COVID-19 ãšè·å Žã®ããŒã¿ã«ã€ããŠè©³ããç¥ãã«ã¯
çµç¹ãè·å Žã®åéãšãããã€ãŠãªãææ決å®ã«çŽé¢ããŠããä»ãããŒã¿ã¯åŒ·åãªãªãœãŒã¹ã«ãªããŸãããããããªã¹ã¯ã«ãããããŠããã®ã¯å¥åº·ãšå®å šã§ãããããçµç¹ã¯åæ§ã«ããã®ããŒã¿ã®åææ åœè ã®èœåéçºã«ãæè³ããå¿ èŠãªå Žåã¯é²ãã¹ãéã®ã¢ããã€ã¹ãå€éšã®å°é家ã«æ±ããªããã°ãªããŸããã
ä»ã® COVID-19 é¢é£ãªãœãŒã¹ãã芧ãã ããã
- COVID-19 ããŒã¿ããã§ã¯ãæ¥çå¥ã®ããŒã¿è¿œè·¡ããžã¥ã¢ã©ã€ãŒãŒã·ã§ã³ãèŠãŠãããŠã³ããŒãå¯èœãªã¯ãŒã¯ããã¯ã§ç¬èªã®åæãå§ããããšãã§ããŸãã
- Salesforce 瀟㮠Work.com ã§ã¯ãäŒæ¥ãå®å šãã€å¹ççã«è·å Žãåéã§ããããã«æ¯æŽããéèŠãªãœãªã¥ãŒã·ã§ã³ãæäŸãããŠããŸãã
- Salesforce 瀟ã°ããŒãã«äžåç£éšéãšã°ãŒã¯ãã£ããã€ã¹ãã¬ãžãã³ãã® Elizabeth Pinkham ã«ããããªãã£ã¹ã«æ»ãããã®æé ã¬ã€ã (è±èª) ããèªã¿ãã ããã
é¢é£ã¹ããŒãªãŒ
Subscribe to our blog
Tableau ã®ææ°æ å ±ãã¡ãŒã«ã§ãç¥ããããŸã